Cytek Biosciences Narrows FY2025 Sales Guidance from $196.000M-$210.000M to $196.000M-$205.000M vs $198.301M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Cytek Biosciences (NASDAQ:CTKB) narrows FY2025 sales outlook from $196.000 million-$210.000 million to $196.000 million-$205.000 million vs $198.301 million estimate.
Cytek Biosciences (NASDAQ:CTKB) narrows FY2025 sales outlook from $196.000 million-$210.000 million to $196.000 million-$205.000 million vs $198.301 million estimate.